Loading clinical trials...
Loading clinical trials...
Obsessive-compulsive disorders are very damaging illnesses that can already manifest in childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most frequently diagnosed psychiatric illness in these age groups. With the further use of data, the treatment success can be significantly improved; causal variables/predictors can be recognized, understood and taken carefully into account. The anticipated incremental knowledge will ultimately help children and young people with obsessive-compulsive disorders to receive faster and more effective treatment.
Age
4 - 18 years
Sex
ALL
Healthy Volunteers
No
Psychiatric University Clinics, Department of Child and Adolescent Psychiatry
Zurich, Canton of Zurich, Switzerland
Start Date
May 1, 2020
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
May 13, 2025
625
ESTIMATED participants
Lead Sponsor
Susanne Walitza
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05623306